Credit Suisse Ag Organogenesis Holdings Inc. Transaction History

Credit Suisse Ag

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$2.34 - $4.43 $24,527 - $46,435	10,482 Added 26.21%	50,482 $160,000
Q2 2023 Aug 11, 2023	SELL	$1.9 - $4.3 $84,071 - $190,266	-44,248 Reduced 52.52%	40,000 $132,000
Q1 2023 May 10, 2023	BUY	$1.89 - $2.93 $28 - $43	15 Added 0.02%	84,248 $179,000
Q4 2022 Feb 13, 2023	SELL	$2.48 - $3.43 $70,980 - $98,170	-28,621 Reduced 25.36%	84,233 $226,000
Q3 2022 Nov 10, 2022	BUY	$3.14 - $6.43 $62,464 - $127,911	19,893 Added 21.4%	112,854 $365,000
Q2 2022 Aug 12, 2022	BUY	$4.74 - $8.15 $15,784 - $27,139	3,330 Added 3.72%	92,961 $454,000
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $13,392 - $19,809	2,070 Added 2.36%	89,631 $683,000
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $630,416 - $943,528	69,891 Added 395.53%	87,561 $809,000
Q3 2021 Nov 12, 2021	SELL	$13.71 - $17.18 $150,110 - $188,103	-10,949 Reduced 38.26%	17,670 $252,000
Q2 2021 Aug 16, 2021	BUY	$14.92 - $23.23 $426,995 - $664,819	28,619 New	28,619 $475,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.